Status:
COMPLETED
The Prevent Anal Cancer Palpation Study
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
University of Chicago
M.D. Anderson Cancer Center
Conditions:
Anal Cancer
Eligibility:
MALE
25+ years
Phase:
NA
Brief Summary
Anal cancer is a common cancer among men having sex with men (MSM). We will investigate increasing detection of anal canal tumors through self- or partner-palpation of the anal canal among MSM and tra...
Detailed Description
Even though expert opinion recommends annual digital ano-rectal exams (DARE) for detection of anal cancer tumors among men having sex with men (MSM), the procedure is severely underutilized by clinici...
Eligibility Criteria
Inclusion
- Chicago or Houston Metro Residents
- Persons who had sex with men in the prior five years
- Cis-gendered men and transgender persons
- Age: 25 years and over
- Access to medical care for referral or treatment
- Spanish or English speakers/readers
- Individuals or couples
- HIV+ or HIV-
- Persons with or without comorbidities and physical disabilities
Exclusion
- Unresolved health care provider's diagnosis of anal condyloma, hemorrhoids or anal cancer
- DARE in the prior three months
- Plans to move in the following six months
Key Trial Info
Start Date :
January 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2023
Estimated Enrollment :
718 Patients enrolled
Trial Details
Trial ID
NCT04090060
Start Date
January 17 2020
End Date
June 10 2023
Last Update
July 9 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
3
M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
4
Gordon Crofoot MD
Houston, Texas, United States, 77098